BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 27029430)

  • 1. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
    Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
    Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
    J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
    Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.
    Du XL; Edelstein D; Dimmeler S; Ju Q; Sui C; Brownlee M
    J Clin Invest; 2001 Nov; 108(9):1341-8. PubMed ID: 11696579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp90 regulates O-linked β-N-acetylglucosamine transferase: a novel mechanism of modulation of protein O-linked β-N-acetylglucosamine modification in endothelial cells.
    Zhang F; Snead CM; Catravas JD
    Am J Physiol Cell Physiol; 2012 Jun; 302(12):C1786-96. PubMed ID: 22496241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus.
    Heath JM; Sun Y; Yuan K; Bradley WE; Litovsky S; Dell'Italia LJ; Chatham JC; Wu H; Chen Y
    Circ Res; 2014 Mar; 114(7):1094-102. PubMed ID: 24526702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
    Goldberg H; Whiteside C; Fantus IG
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
    Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
    Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-linked beta-N-acetylglucosamine (O-GlcNAc) regulates stress-induced heat shock protein expression in a GSK-3beta-dependent manner.
    Kazemi Z; Chang H; Haserodt S; McKen C; Zachara NE
    J Biol Chem; 2010 Dec; 285(50):39096-107. PubMed ID: 20926391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced
    Hodrea J; Balogh DB; Hosszu A; Lenart L; Besztercei B; Koszegi S; Sparding N; Genovese F; Wagner LJ; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F1017-F1029. PubMed ID: 32116017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
    Xu C; Liu G; Liu X; Wang F
    Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
    Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
    BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy.
    Otomo H; Nara M; Kato S; Shimizu T; Suganuma Y; Sato T; Morii T; Yamada Y; Fujita H
    Metabolism; 2020 Dec; 113():154405. PubMed ID: 33069809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
    Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
    Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.